Kelly’s Clinic

06/11/2026

Blood sugar and FSH at first presentation.
Kelly's Clinic · Ottawa, Ontario · 2023–2026 · N = 563 · first visit · before treatment
FSH below 30 IU/L: 16.8% — 50 of 298 FSH at or above 30 IU/L: 33.2% — 88 of 265
FSH threshold: standard clinical reference (≥30 IU/L). Pre-diabetic threshold: WHO/ADA HbA1c ≥5.7%.
FSH has been understood as a reproductive signal. Research from Mount Sinai is now identifying FSH receptors in fat tissue, bone, and brain —independent of the ovaries. Its role in metabolic health is actively being studied.
This pattern was observed in a practice cohort.
Observational data · not medical advice Kelly Knoll, NP

06/08/2026

337 paired trajectories.

Four estradiol patterns.

One metabolic outcome: HbA1c.

When estradiol rose above 200 pmol/L:

63.4% improved HbA1c.

When estradiol stayed below 200 pmol/L:

44.8% improved HbA1c.

That is a 18.6 percentage-point difference between the groups.

This does not prove cause and effect.

It does show a visible pattern:

The group with optimized estradiol had the highest rate of HbA1c improvement.

06/07/2026

The most important practical lesson is to teach what to observe. How to observe.

Observation tells us how the patient is. Reflection tells what is to be done. The numbers tell what cannot be argued with.

I have found that the symptoms considered inevitable — the fatigue, the sleeplessness, the loss of self — are very often not symptoms of the condition at all. They are symptoms of something measurable. Something remediable. Something that went unlooked for.

What nursing has to do is put the patient in the best condition for nature to act.

You cannot do this without first knowing what you are working with.

Count. Measure. Record. Then act.

Making the invisible undeniable.

— F.N.

06/06/2026

I spent ten years in palliative care. I knew suffering.

Nothing prepared me for watching women in midlife — joint pain, frozen shoulders, exhaustion, fear — cycling through specialists and coming back not with answers, but with a new wound.

“Get a job. Get a hobby. Get a life.”

We didn’t have the hormonal lens yet. We didn’t have the evidence. These women had decades left to live and we had very little to offer them.

That changed. The evidence matured. Options exist now.

To the women I witnessed in those years — I’m so sorry. I saw you.

Women over 60 are my priority. Forever.

— Kelly Knoll, RN(EC), PHCNP, CMT

06/05/2026

Everyone Matters .. l

06/04/2026

Melinda French Gates just described exactly why private menopause care exists. She didn't mean to. But she did.
She wrote that women walk into their doctor's office with sleep destroyed, joints aching, heart racing, memory slipping — and walk out with no diagnosis, no treatment and no plan. She wrote that solidarity is no substitute for systemic change. She wrote that less than a third of OB-GYN programs teach this. That 5 cents of every research dollar goes to women's health. That even she — 25 years in women's health advocacy, access to the best care in the world — had to raise the topic herself and push for options.
When the public system sends women home with nothing, and solidarity is no substitute for systemic change — someone has to show up. That's not a business model. That's a response to abandonment.
To the voices in medicine who profit from the knowledge gap through books, speaking fees and media — then call the clinicians filling it the problem:
The women who need help cannot wait for the book tour to end and for you to open a publicly funded clinic. Writing about the crisis is not the same as getting out your prescription pad.
In Canada, we have the bones of something better — universal healthcare, Pharmacare negotiations underway. But until body-identical HRT is named in those bilateral agreements, and until our training gap closes, private menopause care isn't a privilege. It's the only door that's actually open.

06/04/2026

"It fell to me to raise the topic with my doctor and push for options to manage my symptoms."

That's Melinda French Gates. Twenty-five years in women's health advocacy. Access to the best healthcare in the world. And she still had to fight for her own menopause care.

She just committed $600 million to change that. Because the system — as it stands — is failing women at scale.

The numbers are not subtle:
→ 1 in 3 women over 40 has severe menopause symptoms
→ Only 1 in 4 receives any treatment
→ Less than 5% of postmenopausal women are using hormone therapy — the most effective tool we have
→ Less than ⅓ of OB-GYN residency programs teach menopause care
→ 5 cents of every global R&D dollar goes to women's health
→ $26 billion lost annually in medical costs and missed work

Some voices in medicine argue that private menopause care is the problem — that it profits from a system failure that should be fixed publicly. In an ideal world, they're not wrong about the destination. But that argument asks symptomatic women to wait while the system catches up. And the system has been "catching up" for decades.

Private menopause care in Canada doesn't exist because someone saw a market opportunity. It exists because women walked into the public system and walked out with nothing. That's not a business model. That's a response to abandonment.

We have the bones of something better in Canada — universal healthcare, Pharmacare negotiations underway. But until body-identical hormone therapy is named in those bilateral agreements, and until our training gap closes, the door that's actually open is this one.

The knowledge gap is reducing. The evidence is loud. And the most powerful philanthropist in women's health just put $600 million behind what we already knew.

06/03/2026

Everyone worries about access to doctors.

Nobody talks about what a hospital looks like without BSN nurses.

The charge nurse coordinating your care. The nurse who catches the medication interaction at 2am. The one who knows you’re not ready to go home yet — and says so. The bed bath that’s really a head-to-toe assessment in disguise.

This is advanced clinical skill. Years of education, judgment, surveillance. The person standing between you and the thing that was about to go wrong.

That’s what’s being cut right now. Quietly. In the name of cost savings.

You won’t feel the loss today. Most people won’t feel it until they’re the patient in the bed, alone, wondering why no one has come.

Nursing isn’t support staff. It’s the system .

06/03/2026

3 medications approved for alcohol use disorder in 75 years. 8 GLP-1-class drugs now in trials — simultaneously. The last 75 years of treatment for one of the world's most common disorders fit on one hand. The next 5 might change everything. Klausen et al., The Lancet, Vol 407, May 2, 2026, pp. 1687–1698.

06/02/2026